NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
Clinical Trials
4 trialsNCT00634504 2022-06-06
LVPK
BTG International Inc.
Phase 1 Completed
NCT00634322 2014-09-15
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
BTG International Inc.
Phase 2 Terminated
NCT00481559 2014-01-17
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
BTG International Inc.
Approved for marketing